Results, Reports and Publications
Latest Results
Clariant delivers strong underlying margin improvement in the second quarter and increases 2024 profitability outlook to ~ 16 % EBITDA margin
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
- Q2 2024 sales decreased by 3 % organically in local currencies1 to CHF 1.056 billion as growth in Care Chemicals and Adsorbents & Additives was offset by an expected decline in Catalysts
- Q2 2024 reported EBITDA margin decreased to 15.7 % compared to 16.1 % in Q2 2023, underlying improvement excluding prior year’s disposal gain of more than 500 basis points driven by positive operating leverage and reduced sunliquid® impact
- H1 2024 sales decreased by 5 % organically in local currencies1 to CHF 2.070 billion
- H1 2024 reported EBITDA margin improved to 16.4 % compared to 15.0 % in prior year
- H1 2024 Operating Cash Flow at CHF 112 million, compared to CHF 78 million in H1 2023; strong Free Cash Flow Conversion (LTM) of 42 %
- Outlook 2024: Flat to low single-digit percent sales growth in local currency, increase in expected reported EBITDA margin by 100 basis points to around 16.0 %, medium-term targets confirmed
"Clariant delivered a strong underlying margin improvement in the second quarter of 2024 toward 16 %. This progress results from successfully implementing our leaner, customer-focused operating model and continued execution of our performance improvement programs. As a result, we benefitted from improved operating leverage as we achieved growth in our Care Chemical and Adsorbents & Additives businesses while maintaining pricing discipline. We are pleased with the improved cash generation in the first half of 2024 and the progress in our strategic initiatives. The integration of Lucas Meyer Cosmetics is well on track. In addition, our sale of the Podari plant assets and disciplined execution of the downsizing of the bioethanol business will lead to a CHF 20 million lower financial impact than originally expected. Due to this improvement, together with the strong operational performance in the first six months of 2024, we have increased our profitability guidance by 100 basis points for the full year although we expect no signs of a broad market recovery in the second half of the year. 2024 will be a meaningful step towards our medium-term targets." said Conrad Keijzer, Chief Executive Officer of Clariant.
1 All references to local currency growth, pricing, volumes, and scope exclude the impact from hyperinflation countries Argentina and Türkiye. All references to currency include a net impact from hyperinflation countries Argentina and Türkiye.
Read more
Upcoming Results
On 29 October 2024, Clariant will present its Third Quarter / Nine Month Figures 2024.
The results will be published at 7.00 AM CET and a conference call and webcast for analysts and investors will start at 3.00 PM CET.
Conference call participants are kindly requested to register here.
Results Center
Please use the Results Center to find Clariant’s financial results and associated documents as published in the last five years
Q1 Q2 Q3 Q4 Date 5 May 2023 28 July 2023 30 October 2023 29 February 2024 Quiet Period as of 17 April as of 10 July as of 10 October as of 15 January Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript EN EN EN EN Financial Review / HY Report EN EN — XLS Annual Report EN
Q1 Q2 Q3 Q4 Date 15 June 2022 28 July 2022 27 October 2022 2 March 2023 Quiet Period as of 11 July as of 10 October as of 17 February Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
EN Financial Review / HY Report EN EN Annual Report EN
Q1 Q2 Q3 Q4 Date 29 April 2021 29 July 2021 28 October 2021 19 May 2022 Quiet Period as of 19 April as of 12 July as of 18 October Media Release EN — DE EN — DE EN — DE EN — DE Analyst Presentation EN EN EN EN Webcast Audio recording MP3 MP3 MP3 MP3 Transcript
Financial Review / HY Report EN EN Annual Report EN
Conferences and Roadshows
Clariant's Management and Investor Relations Team regularly participates in Conferences and Roadshows. Below you can find an overview of the presentations provided at such events in the last two years.
For an overview of upcoming events, please refer to the Financial Calendar.